{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:45:43Z","timestamp":1776329143682,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008738","name":"Jeanssons Stiftelser","doi-asserted-by":"publisher","award":["2014-0032"],"award-info":[{"award-number":["2014-0032"]}],"id":[{"id":"10.13039\/100008738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016406","name":"Doktor Felix Neuberghs Stiftelse","doi-asserted-by":"publisher","award":["2016-281"],"award-info":[{"award-number":["2016-281"]}],"id":[{"id":"10.13039\/100016406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["S18-0040"],"award-info":[{"award-number":["S18-0040"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["2017-01990"],"award-info":[{"award-number":["2017-01990"]}],"id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007308","name":"Swedish Medical Association","doi-asserted-by":"publisher","award":["SLS-585141"],"award-info":[{"award-number":["SLS-585141"]}],"id":[{"id":"10.13039\/501100007308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.yebeh.2021.108034","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T12:43:22Z","timestamp":1621082602000},"page":"108034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study"],"prefix":"10.1016","volume":"121","author":[{"given":"Zamzam","family":"Mahamud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Zelano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yebeh.2021.108034_b0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1528-1167.2008.01565.x","article-title":"Seizures in multiple sclerosis","volume":"49","author":"Koch","year":"2008","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2021.108034_b0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0022-510X(72)90151-7","article-title":"Epilepsy in multiple sclerosis","volume":"17","author":"Cendrowski","year":"1972","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2021.108034_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.seizure.2018.04.001","article-title":"Treatment of epilepsy in multiple sclerosis","volume":"58","author":"Dagiasi","year":"2018","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2021.108034_b0020","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00415-019-09332-x","article-title":"Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center","volume":"266","author":"Langenbruch","year":"2019","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2021.108034_b0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4065\/76.10.983","article-title":"Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990\u20131998","volume":"76","author":"Nyquist","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.yebeh.2021.108034_b0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11310900-000000000-00000","article-title":"Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management","volume":"23","author":"Kelley","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2021.108034_b0035","doi-asserted-by":"crossref","unstructured":"Koch MW, Polman SK, Uyttenboogaart M, De Keyser J. Treatment of seizures in multiple sclerosis. Cochrane Database Syst Rev. 2009(3):Cd007150.","DOI":"10.1002\/14651858.CD007150.pub2"},{"key":"10.1016\/j.yebeh.2021.108034_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.seizure.2018.11.013","article-title":"Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study","volume":"64","author":"Larsson","year":"2019","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.yebeh.2021.108034_b0045","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2021.108034_b0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1179\/1743132812Y.0000000082","article-title":"Multiple sclerosis and pain","volume":"34","author":"Nick","year":"2012","journal-title":"Neurol Res"},{"key":"10.1016\/j.yebeh.2021.108034_b0055","unstructured":"3, Registry Design. In: Gliklich RE DN, Leavy MB, editor. Registries for evaluating patient outcomes: A user's guide [Internet]. 3 ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014."},{"issue":"9","key":"10.1016\/j.yebeh.2021.108034_b0060","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.seizure.2010.07.013","article-title":"Presence of epileptiform discharges on initial EEGs are associated with failure of retention on first antiepileptic drug in newly diagnosed cryptogenic partial epilepsy: A 2-year observational study","volume":"19","author":"Kim","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2021.108034_b0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.yebeh.2019.04.032","article-title":"Management of seizures in patients with multiple sclerosis; an Iranian consensus","volume":"96","author":"Asadi-Pooya","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108034_b0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10072-004-0362-9","article-title":"Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study","volume":"25","author":"Solaro","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2021.108034_b0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.seizure.2017.09.022","article-title":"The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway","volume":"52","author":"Benjaminsen","year":"2017","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108034_b0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1352458516651502","article-title":"Epilepsy in multiple sclerosis: The role of temporal lobe damage","volume":"23","author":"Calabrese","year":"2017","journal-title":"Mult Scler J"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108034_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458510382246","article-title":"Multiple sclerosis and epileptic seizures","volume":"17","author":"Catenoix","year":"2011","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108034_b0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.seizure.2008.11.006","article-title":"The impact of side effects on long-term retention in three new antiepileptic drugs","volume":"18","author":"Bootsma","year":"2009","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108034_b0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ane.12276","article-title":"Multiple sclerosis and seizures: incidence and prevalence over 40 years","volume":"130","author":"Lund","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108034_b0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1528-1167.2008.01945.x","article-title":"Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108034_b0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/ene.13618","article-title":"Risk of epilepsy after a single seizure in multiple sclerosis","volume":"25","author":"Mahamud","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2021.108034_b0110","doi-asserted-by":"crossref","first-page":"101497","DOI":"10.1016\/j.msard.2019.101497","article-title":"Prognostic impact of epilepsy in multiple sclerosis","volume":"38","author":"Mahamud","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021002687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021002687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:38:58Z","timestamp":1761503938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021002687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":22,"alternative-id":["S1525505021002687"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108034","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108034"}}